Navigating FDA Regulations in Pharma

This chapter examines the FDA's influence on the pharmaceutical market, noting how pre-1962 approval processes may hinder timely access to life-saving drugs. The conversation critiques the current regulatory landscape, highlighting the trend towards 'me too' drugs and the impact of foreign pricing strategies on U.S. consumers. It emphasizes the need for a comprehensive understanding of both drug composition and broader distribution factors in healthcare outcomes.